PMID- 28941656
OWN - NLM
STAT- MEDLINE
DCOM- 20171128
LR  - 20171211
IS  - 1095-6859 (Electronic)
IS  - 0090-8258 (Linking)
VI  - 147
IP  - 3
DP  - 2017 Dec
TI  - Factors influencing fertility-sparing treatment for gynecologic malignancies: A
      survey of Society of Gynecologic Oncology members.
PG  - 497-502
LID - S0090-8258(17)31343-4 [pii]
LID - 10.1016/j.ygyno.2017.09.019 [doi]
AB  - OBJECTIVES: This study aims to examine practice patterns of gynecologic
      oncologists (GO) regarding fertility-sparing treatments (FST) for gynecology
      malignancies and explores attitudes toward collaboration with reproductive
      endocrinologists (RE). METHODS: An anonymous 23-question survey was sent to 1087 
      GO with a 14.0% completion rate. Descriptive statistics, Fisher's exact test, and
      Chi-square tests were used for data analysis. RESULTS: The majority of GOs offer 
      FST for gynecologic malignancies. Providers seeing larger numbers of reproductive
      age women were more likely to consider cancer prognosis (p<0.03) and cancer stage
      (p<0.01) as key factors. Providers in the Midwestern US considered socioeconomic 
      status more often when offering FST than those in the South (p<0.04). Those
      practicing in urban settings were more likely to feel that collaborating with a
      RE prior to treatment could improve treatment planning for women considering FST 
      (p<0.02). Finally, providers in urban or suburban areas more often felt
      collaboration with a RE improves pregnancy outcomes in women who pursue FST
      (p<0.01, p<0.02) compared to rural practitioners. CONCLUSIONS: While FST offers
      women the chance to pursue pregnancy after cancer, there are minimal data on
      factors that influence whether FST is offered and if collaboration with a RE is
      sought in the management of these patients. The number of reproductive age women 
      seen, geographic location, and practice setting are important variables that may 
      influence current practice. Understanding these factors can help identify
      opportunities to improve oncologic and reproductive outcomes of this patient
      population.
CI  - Copyright (c) 2017 Elsevier Inc. All rights reserved.
FAU - Shah, Jaimin S
AU  - Shah JS
AD  - Department of Obstetrics and Gynecology, UT Health, The University of Texas at
      Houston, McGovern Medical School, United States. Electronic address:
      Jaimin.Shah@uth.tmc.edu.
FAU - Guerra, Rosa
AU  - Guerra R
AD  - Department of Obstetrics and Gynecology, UT Health, The University of Texas at
      Houston, McGovern Medical School, United States.
FAU - Bodurka, Diane C
AU  - Bodurka DC
AD  - Department of Gynecologic Oncology and Reproductive Medicine, The University of
      Texas MD Anderson Cancer Center, Houston, TX, United States.
FAU - Sun, Charlotte C
AU  - Sun CC
AD  - Department of Gynecologic Oncology and Reproductive Medicine, The University of
      Texas MD Anderson Cancer Center, Houston, TX, United States.
FAU - Chisholm, Gary B
AU  - Chisholm GB
AD  - Department of Gynecologic Oncology and Reproductive Medicine, The University of
      Texas MD Anderson Cancer Center, Houston, TX, United States.
FAU - Woodard, Terri L
AU  - Woodard TL
AD  - Department of Gynecologic Oncology and Reproductive Medicine, The University of
      Texas MD Anderson Cancer Center, Houston, TX, United States; Department of
      Obstetrics and Gynecology, Division of Reproductive Endocrinology and
      Infertility, Baylor College of Medicine, Houston, TX, United States.
LA  - eng
PT  - Journal Article
DEP - 20170921
PL  - United States
TA  - Gynecol Oncol
JT  - Gynecologic oncology
JID - 0365304
SB  - IM
MH  - Adult
MH  - Female
MH  - Fertility Preservation/economics/methods/*statistics & numerical data
MH  - Genital Neoplasms, Female/economics/pathology/*therapy
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Neoplasm Staging
MH  - Practice Patterns, Physicians'/*statistics & numerical data
MH  - Socioeconomic Factors
MH  - United States
OTO - NOTNLM
OT  - *Early gynecologic cancer
OT  - *Fertility preservation
OT  - *Fertility sparing treatment
OT  - *Health care disparities
OT  - *Practice patterns
OT  - *Provider attitudes
EDAT- 2017/09/25 06:00
MHDA- 2017/11/29 06:00
CRDT- 2017/09/25 06:00
PHST- 2017/07/21 00:00 [received]
PHST- 2017/09/15 00:00 [revised]
PHST- 2017/09/18 00:00 [accepted]
PHST- 2017/09/25 06:00 [pubmed]
PHST- 2017/11/29 06:00 [medline]
PHST- 2017/09/25 06:00 [entrez]
AID - S0090-8258(17)31343-4 [pii]
AID - 10.1016/j.ygyno.2017.09.019 [doi]
PST - ppublish
SO  - Gynecol Oncol. 2017 Dec;147(3):497-502. doi: 10.1016/j.ygyno.2017.09.019. Epub
      2017 Sep 21.